GeneDx Holdings Corp. (WGS) Insider Trading
- $23,323,844.27
- $199,267,136.99
- March 5, 2026
- Kevin Feeley
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 5, 2026 | Director | 140,026 | $81.19 | Buy | $11,368,710.94 | |
| March 4, 2026 | CEO | 25,459 | $78.61 | Sell | $2,001,331.99 | |
| March 4, 2026 | CFO | 6,187 | $78.61 | Sell | $486,360.07 | |
| March 3, 2026 | Director | 29,495 | $70.89 | Buy | $2,090,900.55 | |
| Feb. 4, 2026 | COO | 5,961 | $85.70 | Sell | $510,857.70 | |
| Feb. 2, 2026 | COO | 3,413 | $99.53 | Sell | $339,695.89 | |
| Jan. 29, 2026 | CFO | 317 | $93.99 | Sell | $29,794.83 | |
| Jan. 29, 2026 | CEO | 1,653 | $94.00 | Sell | $155,382.00 | |
| Sept. 16, 2025 | CFO | 3,728 | $121.47 | Sell | $452,840.16 | |
| Sept. 16, 2025 | CEO | 10,501 | $121.47 | Sell | $1,275,556.47 | |
| Sept. 2, 2025 | CFO | 378 | $125.81 | Sell | $47,556.18 | |
| Aug. 27, 2025 | Director | 1,150 | $129.65 | Sell | $149,097.50 | |
| Aug. 22, 2025 | Director | 500,000 | $120.90 | Sell | $60,450,000.00 | |
| July 29, 2025 | CFO | 388 | $105.31 | Sell | $40,860.28 | |
| July 29, 2025 | CEO | 2,154 | $105.31 | Sell | $226,837.74 | |
| July 9, 2025 | CFO | 5,278 | $93.00 | Sell | $490,854.00 | |
| July 9, 2025 | CEO | 3,220 | $93.00 | Sell | $299,460.00 | |
| July 1, 2025 | CFO | 1,344 | $91.12 | Sell | $122,465.28 | |
| July 1, 2025 | CEO | 9,657 | $90.94 | Sell | $878,207.58 | |
| June 2, 2025 | CFO | 370 | $71.26 | Sell | $26,366.20 | |
| May 8, 2025 | Director | 100,000 | $56.01 | Buy | $5,601,000.00 | |
| April 29, 2025 | CFO | 388 | $113.09 | Sell | $43,878.92 | |
| April 29, 2025 | CEO | 2,154 | $113.09 | Sell | $243,595.86 | |
| April 9, 2025 | CEO | 46,594 | $89.62 | Sell | $4,175,754.28 | |
| April 9, 2025 | CFO | 15,516 | $92.18 | Sell | $1,430,264.88 | |
| March 26, 2025 | CEO | 46,551 | $95.62 | Sell | $4,451,206.62 | |
| March 26, 2025 | CFO | 8,746 | $95.61 | Sell | $836,205.06 | |
| March 17, 2025 | CFO | 3,749 | $96.71 | Sell | $362,565.79 | |
| March 17, 2025 | CEO | 10,559 | $96.71 | Sell | $1,021,160.89 | |
| March 13, 2025 | CEO | 1,078 | $89.44 | Sell | $96,416.32 | |
| March 13, 2025 | CFO | 402 | $90.05 | Sell | $36,200.10 | |
| March 10, 2025 | CFO | 922 | $94.72 | Sell | $87,331.84 | |
| March 10, 2025 | CEO | 2,731 | $94.73 | Sell | $258,707.63 | |
| Jan. 29, 2025 | CFO | 275 | $78.48 | Sell | $21,582.00 | |
| Jan. 29, 2025 | CEO | 1,657 | $78.48 | Sell | $130,041.36 | |
| Jan. 7, 2025 | CFO | 35,506 | $93.82 | Sell | $3,331,172.92 | |
| Jan. 7, 2025 | CEO | 51,420 | $94.48 | Sell | $4,858,161.60 | |
| Jan. 2, 2025 | CFO | 1,430 | $76.04 | Sell | $108,737.20 | |
| Jan. 2, 2025 | CEO | 18,006 | $78.18 | Sell | $1,407,709.08 | |
| Dec. 16, 2024 | CFO | 3,728 | $76.75 | Sell | $286,124.00 | |
| Dec. 16, 2024 | CEO | 10,501 | $76.75 | Sell | $805,951.75 | |
| Dec. 9, 2024 | CEO | 3,661 | $76.37 | Sell | $279,590.57 | |
| Dec. 9, 2024 | CFO | 1,137 | $76.37 | Sell | $86,832.69 | |
| Dec. 2, 2024 | CFO | 263 | $78.39 | Sell | $20,616.57 | |
| Nov. 21, 2024 | CFO | 12,019 | $73.76 | Sell | $886,521.44 | |
| Nov. 19, 2024 | Director | 31,510 | $71.28 | Sell | $2,246,032.80 | |
| Nov. 18, 2024 | Major Shareholder | 126,782 | $70.78 | Sell | $8,973,629.96 | |
| Nov. 18, 2024 | CEO | 22,307 | $70.34 | Sell | $1,569,074.38 | |
| Nov. 15, 2024 | CEO | 23,108 | $70.48 | Sell | $1,628,651.84 | |
| Nov. 15, 2024 | Major Shareholder | 20,359 | $69.78 | Sell | $1,420,651.02 |
Insiders are both buying and selling GeneDx Holdings Corp. stock.
The insider traders at GeneDx Holdings Corp. are: Kevin Feeley, Katherine Stueland, Opko Health, Inc., Kareem Saad, Karen Ann White, Casdin Capital, Llc, Jason Ryan, School Of Medicine At Mo Icahn, Keith A Meister, Richard C Pfenniger Jr, and Bryan Dechairo
The most active insider trader at GeneDx Holdings Corp. is Kevin Feeley with 39 trades.
Casdin Capital, Llc has sold the most GeneDx Holdings Corp. stock with a total value of $120,900,000.00.
Keith A Meister has bought the most GeneDx Holdings Corp. stock with a total value of $30,429,322.43.
The most recent insider trade for GeneDx Holdings Corp. was on March 5, 2026.
The single biggest insider buy for GeneDx Holdings Corp. was from Keith A Meister with a total value of $11,368,710.94 on March 5, 2026.
The single biggest insider sell for GeneDx Holdings Corp. was from School Of Medicine At Mo Icahn with a total value of $64,935,000.00 on Oct. 31, 2024.